Company facts
BioMarkIQ,
at a glance.
The company, our first product, and the science behind it.
UPDATED 17 OCTOBER 2026Machine-readable facts
BioMarkIQ is developing biomarker panels and machine learning for earlier cancer detection, one disease at a time.
Development direction; no clinical performance or availability claim.
VarSee Lung is BioMarkIQ’s initial lung-cancer development focus.
Does not establish clinical availability, approval, or performance.
BioMarkIQ’s mixture-of-experts approach connects specialist machine-learning models through contextual gating.
Conceptual architecture; not a claim about a deployed model or evaluated performance.
VarSee Lung is available for research use only. Not for diagnostic use.
Research-use availability only; no diagnostic use, regulatory approval, or performance claim.